In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5
- PMID: 9573273
- PMCID: PMC110066
- DOI: 10.1128/JVI.72.6.5035-5045.1998
In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5
Abstract
We have evaluated the in vivo distribution of the major human immunodeficiency virus/simian immunodeficiency virus (HIV/SIV) coreceptors, CXCR4, CCR3, and CCR5, in both rhesus macaques and humans. T lymphocytes and macrophages in both lymphoid and nonlymphoid tissues are the major cell populations expressing HIV/SIV coreceptors, reaffirming that these cells are the major targets of HIV/SIV infection in vivo. In lymphoid tissues such as the lymph node and the thymus, approximately 1 to 10% of the T lymphocytes and macrophages are coreceptor positive. However, coreceptor expression was not detected on follicular dendritic cells (FDC) in lymph nodes, suggesting that the ability of FDC to trap extracellular virions is unlikely to be mediated by a coreceptor-specific mechanism. In the thymus, a large number of immature and mature T lymphocytes express CXCR4, which may render these cells susceptible to infection by syncytium-inducing viral variants that use this coreceptor for entry. In addition, various degrees of coreceptor expression are found among different tissues and also among different cells within the same tissues. Coreceptor-positive cells are more frequently identified in the colon than in the rectum and more frequently identified in the cervix than in the vagina, suggesting that the expression levels of coreceptors are differentially regulated at different anatomic sites. Furthermore, extremely high levels of CXCR4 and CCR3 expression are found on the neurons from both the central and peripheral nervous systems. These findings may be helpful in understanding certain aspects of HIV and SIV pathogenesis and transmission.
Figures








Similar articles
-
Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.J Virol. 2000 Aug;74(15):6893-910. doi: 10.1128/jvi.74.15.6893-6910.2000. J Virol. 2000. PMID: 10888629 Free PMC article.
-
Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.Virology. 1998 Jun 20;246(1):113-24. doi: 10.1006/viro.1998.9174. Virology. 1998. PMID: 9656999
-
Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo.J Virol. 1999 Sep;73(9):7795-804. doi: 10.1128/JVI.73.9.7795-7804.1999. J Virol. 1999. PMID: 10438870 Free PMC article.
-
Chemokine receptors and virus entry in the central nervous system.J Neurovirol. 1999 Dec;5(6):643-58. doi: 10.3109/13550289909021293. J Neurovirol. 1999. PMID: 10602405 Review.
-
Chemokine receptors and human immunodeficiency virus infection.Front Biosci. 1998 Jan 1;3:d44-58. doi: 10.2741/a265. Front Biosci. 1998. PMID: 9407151 Review.
Cited by
-
Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease.J Virol. 2000 Jan;74(1):184-92. doi: 10.1128/jvi.74.1.184-192.2000. J Virol. 2000. PMID: 10590105 Free PMC article.
-
Chemokine receptors and neural function.J Neurovirol. 2002 Dec;8(6):573-84. doi: 10.1080/13550280290101003. J Neurovirol. 2002. PMID: 12476351 Review.
-
Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles.Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2373-8. doi: 10.1073/pnas.96.5.2373. Proc Natl Acad Sci U S A. 1999. PMID: 10051649 Free PMC article.
-
Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interaction.J Virol. 1999 May;73(5):3603-7. doi: 10.1128/JVI.73.5.3603-3607.1999. J Virol. 1999. PMID: 10196251 Free PMC article.
-
Microglial activation varies in different models of Creutzfeldt-Jakob disease.J Virol. 1999 Jun;73(6):5089-97. doi: 10.1128/JVI.73.6.5089-5097.1999. J Virol. 1999. PMID: 10233972 Free PMC article.
References
-
- Alkhatib G, Combadiere C, Broder C C, Feng Y, Kennedy P E, Murphy P M, Berger E A. CC CKR5: a RANTES, MIP1-alpha, MIP1-beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272:1955–1958. - PubMed
-
- Bahner I, Kearns K, Coutinho S, Leonard E H, Kohn D B. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood. 1997;90:1787–1798. - PubMed
-
- Broder C C, Dimitrov D S, Blumenthal R, Berger E A. The block of HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s) Virology. 1993;193:483–491. - PubMed
-
- Burkitt H G, Young B, Heath J W. Functional histology. 3rd ed. New York, N.Y: Churchill Livingstone; 1994.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources